Besides HCC, the CyPJ gene is also aberrantly dysregulated in several other malignancies such as breast, prostate, and ovarian cancers (Supplementary Figure S2) (Qi et al., 2005; Couch et al., 2016; Gong et al., 2017). This evidence concerns the gene PPIL3 and ovarian cancer.